Eli Lilly And reported $6.49B in Sales Revenues for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbott ABT:US $ 11257M 638M
Abbvie ABBV:US $ 14583M 1045M
ALKERMES ALKS:US $ 276.22M 2.33M
Amgen AMGN:US $ 6594M 356M
Astrazeneca AZN:US $ 10771M 619M
AstraZeneca AZN:LN 10771M 619M
Baxter International BAX:US $ 3746M 39M
Biogen BIIB:US $ 2589.1M 57.3M
Bristol Myers Squibb BMY:US $ 11887M 239M
Catalent CTLT:US $ 1273M 56M
Coherus Biosciences CHRS:US $ 60.15M 0.04M
Eli Lilly And LLY:US $ 6488M 1322M
Endo International Ordinary Shares ENDP:US $ 652.26M 137.17M
Gilead Sciences GILD:US $ 6260M 330M
Glaxosmithkline GSK:US $ 6929M 2851M
GlaxoSmithKline GSK:LN 6929M 2851M
Horizon Pharma HZNP:US $ 876.41M 8.83M
Intercept Pharmaceuticals ICPT:US $ 71.76M 16.82M
JAZZ PHA JAZZ:US $ 932.88M 119.16M
Johnson & Johnson JNJ:US $ 24020M 594M
Lannett LCI:US $ 78.36M 8.15M
Medtronic MDT:US $ 8089M 326M
Merk MRK:US $ 14593M 1308M
Neurocrine Biosciences NBIX:US $ 378.2M 67.6M
Novartis NVS:US $ 13085M 271M
Novartis NOVN:VX SF 13085M 271M
Perrigo Ordinary Shares PRGO:US $ 1074.5M 30.4M
Pfizer PFE:US $ 27742M 2081M
Phibro Animal Health PAHC:US $ 239.62M 6.91M
Prestige Brands PBH:US $ 277.06M 10.12M
Regeneron Pharmaceuticals REGN:US $ 2857.2M 107.9M
Revance Therapeutics RVNC:US $ 25.26M 0.69M
Roche Holding ROG:VX 16.44B 474M
Teva Pharmaceutical Industries TEVA:US $ 3786M 125M
United Therapeutics UTHR:US $ 466.9M 5M
Zoetis ZTS:US $ 2052M 66M